Rezo Therapeutics
Latest round
- Series A
Last raised
- Nov 2022
Total raised
- $15M
Investors
- 6
About Rezo Therapeutics
Based in California, US, and co-founded by Nevan Krogan (CEO), Kevan Shokat, Sourav Bandyopadhyay (CSO), Natalia Jura, George Scangos (Chairperson), and Norbert Bischofbergerin, Rezo Therapeutics, Inc. operates as a biopharmaceutical company that focuses on developing a technology platform to enhance the success rate of drug development. The company offers a Sequence to Systems to Drugs (SSD) platform that through computational methods enables the integration of data from proteomics, genetics, structural biology, and chemical biology and creates comprehensive maps of molecular disease networks to provide more complete and rapid view of mechanisms that causes disease. The platform through artificial intelligence and machine learning, identifies and study disease-causing protein and genetic interactions, and elevates the rate of medication development and its effectiveness for a range of diseases. Rezo as of January 2023 is initially focusing on oncology.
Who invested in Rezo Therapeutics
6 investors across 1 round
See all investors in Rezo Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 17, 2022
Amount
$15M
Investors
Questions about Rezo Therapeutics
Who invested in Rezo Therapeutics?
Rezo Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rezo Therapeutics raised?
Rezo Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Rezo Therapeutics last raise money?
Rezo Therapeutics's most recent round on record is a Series A, in Nov 2022.
What does Rezo Therapeutics do?
Based in California, US, and co-founded by Nevan Krogan (CEO), Kevan Shokat, Sourav Bandyopadhyay (CSO), Natalia Jura, George Scangos (Chairperson), and Norbert Bischofbergerin, Rezo Therapeutics, Inc.
Where is Rezo Therapeutics headquartered?
Rezo Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Rezo Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Rezo Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Rezo Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.